Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.20.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Current Assets:    
Cash and Cash Equivalents $ 5,877,983 $ 3,776,712
Prepaid Expenses and Other Current Assets 366,065 458,810
Right-of-Use Assets 145,064 83,926
Current Portion of Refundable Tax Credit Receivable 5,344 4,857
Total Current Assets 6,394,456 4,324,305
Property and Equipment, Net 16,029 16,846
Restricted Cash 45,000 45,000
Goodwill 1,525,896 1,525,896
Intangible Assets and In-Process R&D, Net 4,124,814 4,131,064
Other Assets 81,019 69,403
Total Assets 12,187,214 10,112,514
Current Liabilities:    
Accounts Payable 158,026 210,289
Accrued Expenses 491,084 1,120,480
Lease Liabilities 145,064 83,926
Total Current Liabilities 794,174 1,414,695
Non-Current Liabilities:    
Contingent Consideration 1,710,000 1,710,000
Deferred Tax Liability 365,364 365,364
Total Non-Current Liabilities 2,075,364 2,075,364
Total Liabilities 2,869,538 3,490,059
Commitments and Contingencies (Note 10)
Stockholders' Equity:    
Preferred Stock, $0.01 Par Value: 9,994,184 shares authorized; 3,750 designated Series A, 0 shares issued and outstanding at March 31, 2020 and December 31, 2019; 10,000 designated Series B, 0 shares issued and outstanding at March 31, 2020 and December 31, 2019; 10,000 shares designated Series C, 4,092 shares issued and outstanding at March 31, 2020 and December 31, 2019 41 41
Common Stock, $0.01 Par Value: 120,000,000 shares authorized; 4,626,755 and 4,077,755 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively 46,268 40,778
Additional Paid-In Capital 111,330,808 106,689,065
Accumulated Deficit (102,199,094) (100,246,894)
Accumulated Other Comprehensive Income 139,653 139,465
Total Stockholders' Equity 9,317,676 6,622,455
Total Liabilities and Stockholders' Equity $ 12,187,214 $ 10,112,514